DICER1 and pancreatic neoplasm: Our laboratory’s prior research has also found that ERK-mediated SP1 transcription factor binds to the Dicer promoter region and induces increased Dicer expression, contributing to the survival of gemcitabine-resistant pancreatic cancer cells [8].